Several companies will receive grants to develop hepatitis C molecular point-of-care and core antigen diagnostic assays.
The grant is the second in the last six months that the Paul G. Allen Family Foundation has awarded to Chembio for diagnostics development.
Grants awarded to Chembio, BD, and FIND will help fund new diagnostic tests for Ebola and other fever-inducing illnesses and feasibility studies to evaluate them.
NEW YORK (GenomeWeb News) – Genisphere said today it has licensed its 3DNA Signal Amplification technology to Chembio Diagnostics.
Chembio Diagnostics has published a study demonstrating the utility of its antibody-based Dual Path Platform point-of-care test for syphilis.
Agilent has named Lars Holmkvist as a senior vice president and president of its Diagnostics and Genomics group.
A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.
South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.
In Science this week: the synthetic genetic system hachimoji, and more.
Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.